upper eyelid ptosis left; after the 2nd vaccination left-sided facial paralysis; myasthenia gravis; double vision left eye; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: at-basgages-2022-011641 . a 63 year-old male patient received bnt162b2 (comirnaty), administration date 17may2021 (lot number: fa4598) as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: comirnaty (dose 1, single), for covid-19 immunisation. the following information was reported: eyelid ptosis (medically significant) with onset 19may2021, outcome "recovered", described as "upper eyelid ptosis left"; facial paralysis (medically significant) with onset 19may2021, outcome "recovered", described as "after the 2nd vaccination left-sided facial paralysis"; myasthenia gravis (medically significant) with onset 19may2021, outcome "recovered", described as "myasthenia gravis"; diplopia (medically significant) with onset 19may2021, outcome "recovered", described as "double vision left eye". no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : -pfizer inc-202200259281 2nd/3rd dose